128
Views
36
CrossRef citations to date
0
Altmetric
Original Articles

Inhibition of Topoisomerases by Antitumor Prostaglandins.

, &
Pages 2073-2075 | Received 25 Jun 1998, Published online: 22 May 2014

  • 1) Kato, T., Fukushima, M., Kurozumi, S., and Noyori, R., Antitumor activity of Δ 7-prostaglandin A1 and Δ 12-prostaglandin J2 in vitro and in vivo. Cancer Res, 46, 3538-3542 (1986).
  • 2) Sasaki, H., Takada, K., Terashita, Y., Ekimoto, H., Takahashi, K., Tsuru, T., and Fukushima, M., Human ovarian cancer cell lines resistant to cisplatin, doxorubicin, and L-phenylalanine mustard are sensitive to Δ 7-prostaglandin A1 and Δ 12-prostaglandin J2. Gynecologic Oncology, 41, 36-40 (1991).
  • 3) Ohno, K., Fukushima, M., Fujiwara, M., and Narumiya, S., Induction of 68,000-dalton heat shock proteins by cyclopentenone prostaglandins: Its association with prostaglandin-induced G1 block in cell cycle progression. J. Biol. Chem., 263, 19764-19770 (1988).
  • 4) Ohno, K., Sakai, T., Fukushima, M., Narumiya, S., and Fujiwara, M., Site and mechanism of growth inhibition by prostaglandins: IV: Effect of cyclopentenone prostaglandins on cell cycle progression of G1-enriched HeLa S3 cells. J. Pharmacol. Exp. Ther., 245, 294-298 (1988).
  • 5) Forman, B. E., Tontonoz, P., Chen, J., Brun. R. P., Spiegelman, B. M. and Evans, R. M., 15-Deoxy-delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell, 83, 803-812 (1995).
  • 6) Hitomi, M., Shu, J., Strom, D., Hiebert, S. W., Harter, M. L., and Stacey, D. W., Prostaglandin A2 blocks the activation of G1 phase cyclin-dependent kinase without altering mitogen-activated protein kinase stimulation. J. Biol. Chem., 271, 9376-9383 (1996).
  • 7) Gorspe, M., Wang, X., Guyton, K. Z., and Holbrook, N. J., Protective role of p21 (Waf1/Cip1) against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells. Mol. Cell. Biol, 16, 6654-6650 (1996).
  • 8) Higashiyama, K., Niiya, K., Ozawa, T., Hayakawa, Y., Fujimaki, M., and Sakuragawa, N., Induction of c-fos protooncogene transcription and apoptosis by delta 12-prostaglandin J2 in human P1-21 myeloid leukemia and RC-K8 pre-B lymphoma cells. Prostaglandins, 52, 143-156 (1996).
  • 9) Rossi, A., Elia, G., and Santoro, M. G., Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation. Proc. Natl. Acad. Sci. U.S.A., 94, 746-750 (1997).
  • 10) Suzuki, M., Mori, M., Niwa. T., Hirata, R., Furuta, K., Ishikawa, T., and Noyori, R., Chemical implications for antitumor and antiviral prostaglandins: reaction of Δ 7-prostaglandin A1 and prostaglandin A1 methyl esters with thiols. J. Am. Chem. Soc., 119, 2376-2385 (1997).
  • 11) Suzuki, K., Siddique, T., Nishimura, H., Sekimoto, J., and Uyeda, M., Inhibition of DNA topoisomerases by microbial inhibitors. J. Enz. Inhib., 13, 41-55 (1998).
  • 12) Suzuki, K., Sekimoto, J., Siddique, T., Kamiya, A., and Uyeda, M., Macrostatin, a novel macromolecular inhibitor of topoisomerases produced by Streptomyces avermitilis No. C-127. J. Enz. Inhib.(1998) in press.
  • 13) Wang, J. C., DNA topoisomerases. Annu. Rev. Biochem., 54, 665-697 (1985).
  • 14) D’Arpa, P., and Liu, L.F., Topoisomerase-targeting antitumor drugs. Biochim. Biophys. Acta, 989, 163-177 (1989).
  • 15) Liu, L. F., DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem., 58, 351-357 (1989).
  • 16) Ferro, A. M., and Olivera, B. M., Poly (ADP-ribosylation) of DNA topoisomerase I from calf thymus. J. Biol. Chem., 259, 547-554 (1984).
  • 17) Schomburg, U., and Grosse, F., Purification and characterization of DNA topoisomerase II from calf thymus associated with polypeptides of 175 and 150 kDa. Eur. J. Biochem., 160, 451-457 (1986).
  • . 1984. p. 275- 289.
  • 19) Kikawa, Y., Narumiya, S., Fukushima, M., Wakatsuka, H., and Hayashi, O., 9-Deoxy-Δ 9,12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma. Proc. Natl. Acad. Sci. U.S.A., 81, 1317-1321 (1984).
  • 20) Ohno, K., Fujiwara, M., Fukushima, M., and Narumiya, S., Metabolic dehydration of prostaglandin E2 and cellular uptake of the dehydration product: Correlation with prostaglandin E2-induced growth inhibition. Biochem. Biophys. Res. Commun., 139, 808-815 (1986).
  • 21) Narumiya, S., and Fukushima, M., Delta 12-prostaglandin, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition. Biochem. Biophys. Res. Commun., 127, 739-745 (1985).
  • 22) Fukushima, M., Prostaglandin J2, antitumor and antiviral activities and the mechanisms involved. Eicosanoids, 3, 189-199 (1990).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.